phase readout
saveNCT03157635: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
ACTIVE_NOT_RECRUITINGupdated 20d ago
community read0 votes
Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Paroxysmal Hemoglobinuria, Nocturnal
view source ↗
comments(0)
5-min edit window · permanent after that